Search results
May 22, 2021 · Near-infrared photoimmunotherapy (NIR-PIT) is a newly-developed, highly-selective cancer treatment, which utilizes a monoclonal antibody conjugated to a photoabsorbing dye, IRDye700DX (IR700). The antibody conjugate is injected into the patient and accumulates in the tumour.
- Yasuhiro Maruoka, Yasuhiro Maruoka, Hiroaki Wakiyama, Peter L. Choyke, Hisataka Kobayashi
- 2021
Jul 23, 2019 · NIR-PIT is a molecularly targeted phototherapy for cancer that is based on injecting a conjugate of a near-infrared, water-soluble, silicon-phthalocyanine derivative, IRdye700DX (IR700), and a monoclonal antibody (mAb) that targets an expressed antigen on the cancer cell surface.
- Hisataka Kobayashi, Peter L. Choyke
- 2019
Yuhei NISHIMURA | Cited by 3,047 | of Mie University, Tsu | Read 196 publications | Contact Yuhei NISHIMURA
Yuhei NISHIMURA | Cited by 2,888 | of Mie University, Tsu | Read 194 publications | Contact Yuhei NISHIMURA
1 day ago · Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 1999;11:141–51.
Reception time: 9:30～17:30. Closed on weekends and holidays. [Kyoto Kitayama Intellectual Property Firm] ― Legal Department ー. [Kyoto Kitayama IP Firm Shiga Office] 京都北山特許法律事務所に在籍する、経験豊富な弁理士や弁護士陣をご紹介。. 知的・産業財産権等に関わる業務案件を強力に ...
Oct 10, 2011 · We report a 64-year-old man and a 65-year-old man with recurrent colorectal cancer without brain metastases; these patients developed multifocal and solitary intracranial hemorrhage, respectively, after the administration of bevacizumab.
